7608 related articles for article (PubMed ID: 1923535)
1. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
Bártek J; Bártková J; Vojtĕsek B; Stasková Z; Lukás J; Rejthar A; Kovarík J; Midgley CA; Gannon JV; Lane DP
Oncogene; 1991 Sep; 6(9):1699-703. PubMed ID: 1923535
[TBL] [Abstract][Full Text] [Related]
2. Expression of mutant p53 in melanoma.
Stretch JR; Gatter KC; Ralfkiaer E; Lane DP; Harris AL
Cancer Res; 1991 Nov; 51(21):5976-9. PubMed ID: 1933861
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies.
Bártek J; Bártková J; Lukás J; Stasková Z; Vojtĕsek B; Lane DP
J Pathol; 1993 Jan; 169(1):27-34. PubMed ID: 8433213
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical demonstration of mutant p53 tumour suppressor gene product in aberrant crypt foci.
Stopera SA; Bird RP
Cytobios; 1993; 73(293):73-88. PubMed ID: 8319499
[TBL] [Abstract][Full Text] [Related]
5. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry.
Bonsing BA; Corver WE; Gorsira MC; van Vliet M; Oud PS; Cornelisse CJ; Fleuren GJ
Cytometry; 1997 May; 28(1):11-24. PubMed ID: 9136751
[TBL] [Abstract][Full Text] [Related]
6. Production of human p53 specific monoclonal antibodies and their use in immunohistochemical studies of tumor cells.
Legros Y; Lacabanne V; d'Agay MF; Larsen CJ; Pla M; Soussi T
Bull Cancer; 1993 Feb; 80(2):102-10. PubMed ID: 7513565
[TBL] [Abstract][Full Text] [Related]
7. p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer.
Elledge RM; Clark GM; Fuqua SA; Yu YY; Allred DC
Cancer Res; 1994 Jul; 54(14):3752-7. PubMed ID: 8033095
[TBL] [Abstract][Full Text] [Related]
8. Studies on p53 immunolocalisation in breast cancer and its prognostic significance.
Meenakshi A; Manoharan V
Hum Antibodies; 1999; 9(3):171-6. PubMed ID: 10690631
[TBL] [Abstract][Full Text] [Related]
9. Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas.
Tominaga O; Hamelin R; Trouvat V; Salmon RJ; Lesec G; Thomas G; Remvikos Y
Oncogene; 1993 Oct; 8(10):2653-8. PubMed ID: 8378077
[TBL] [Abstract][Full Text] [Related]
10. Inter-observer variation of p53 immunohistochemistry--an assessment of a practical problem and comparison with other studies.
Kay EW; Barry Walsh CJ; Whelan D; O'Grady A; Leader MB
Br J Biomed Sci; 1996 Jun; 53(2):101-7. PubMed ID: 8757686
[TBL] [Abstract][Full Text] [Related]
11. Absence of p53 autoantibodies in sera from glioma patients.
Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
[TBL] [Abstract][Full Text] [Related]
12. [Expression of mutant P53 gene protein product in human bladder carcinoma].
Ye DW
Zhonghua Wai Ke Za Zhi; 1993 Aug; 31(8):484-6. PubMed ID: 8112175
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53 protein in normal, dysplastic, and malignant gastric mucosa: an immunohistochemical study.
Joypaul BV; Newman EL; Hopwood D; Grant A; Qureshi S; Lane DP; Cuschieri A
J Pathol; 1993 Jul; 170(3):279-83. PubMed ID: 8133401
[TBL] [Abstract][Full Text] [Related]
14. p53 alterations are associated with improved prognosis in distal colonic carcinomas.
Soong R; Grieu F; Robbins P; Dix B; Chen D; Parsons R; House A; Iacopetta B
Clin Cancer Res; 1997 Aug; 3(8):1405-11. PubMed ID: 9815825
[TBL] [Abstract][Full Text] [Related]
15. Methods in pathology. p53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections.
Terada T; Shimizu K; Izumi R; Nakanuma Y
Mod Pathol; 1994 Feb; 7(2):249-52. PubMed ID: 8008749
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with the proliferation marker, MIB-1.
Beck T; Weller EE; Weikel W; Brumm C; Wilkens C; Knapstein PG
Gynecol Oncol; 1995 Apr; 57(1):96-104. PubMed ID: 7705708
[TBL] [Abstract][Full Text] [Related]
17. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
18. p53 protein immunostaining in routinely processed paraffin-embedded sections.
Bruner JM; Connelly JH; Saya H
Mod Pathol; 1993 Mar; 6(2):189-94. PubMed ID: 8483890
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of mutant p53 oncogene in transitional mucosa adjacent to human colon cancer.
Baytner S; Mitmaker B; Gordon PH; Wang E
Clin Invest Med; 1993 Oct; 16(5):379-85. PubMed ID: 8261691
[TBL] [Abstract][Full Text] [Related]
20. Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid.
van den Berg FM; Baas IO; Polak MM; Offerhaus GJ
Am J Pathol; 1993 Feb; 142(2):381-5. PubMed ID: 8434637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]